RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers

by Tilman D. Rachner, Martina Rauner
Published 2015-10-01

Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies

by Tilman Todenhöfer, Arnulf Stenzl, Lorenz C. Hofbauer, Tilman D. Rachner
Published 2015-01-01

Skeletal endocrinology: where evolutionary advantage meets disease

by Nikolai Jaschke, Wolfgang Sipos, Lorenz C. Hofbauer, Tilman D. Rachner, Martina Rauner
Published 2021-05-01

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin

by Peggy Benad-Mehner, Stefanie Thiele, Tilman D. Rachner, Andy Göbel, Martina Rauner, Lorenz C. Hofbauer
Published 2014-03-01

Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss

by Juliane Lehmann, Sylvia Thiele, Ulrike Baschant, Tilman D. Rachner, Christof Niehrs, Lorenz C. Hofbauer, Martina Rauner
Published 2021-03-01

The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone

by Andy Göbel, Stefania Dell’Endice, Nikolai Jaschke, Sophie Pählig, Amna Shahid, Lorenz C. Hofbauer, Tilman D. Rachner
Published 2021-05-01

Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis

by Daniel Martin Klotz, Daniel Martin Klotz, Daniel Martin Klotz, Jan Dominik Kuhlmann, Jan Dominik Kuhlmann, Jan Dominik Kuhlmann, Theresa Link, Theresa Link, Theresa Link, Maren Goeckenjan, Maren Goeckenjan, Maren Goeckenjan, Lorenz C. Hofbauer, Lorenz C. Hofbauer, Lorenz C. Hofbauer, Andy Göbel, Andy Göbel, Andy Göbel, Tilman D. Rachner, Tilman D. Rachner, Tilman D. Rachner, Pauline Wimberger, Pauline Wimberger, Pauline Wimberger
Published 2022-10-01

Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer

by Andy Göbel, Valentina M. Zinna, Stefania Dell’Endice, Nikolai Jaschke, Jan Dominik Kuhlmann, Pauline Wimberger, Tilman D. Rachner
Published 2020-07-01

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

by Maria Wilke, Andy Göbel, Martina Rauner, Peggy Benad-Mehner, Norbert Schütze, Susanne Füssel, Peyman Hadji, Lorenz C. Hofbauer, Tilman D. Rachner
Published 2014-03-01

Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer

by Andrew J. Browne, Marie L. Kubasch, Andy Göbel, Peyman Hadji, David Chen, Martina Rauner, Friedrich Stölzel, Lorenz C. Hofbauer, Tilman D. Rachner
Published 2017-08-01

Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients

by Andy Göbel, Jan D. Kuhlmann, Theresa Link, Pauline Wimberger, Cornelia Link-Rachner, Stefanie Thiele, Stefania Dell'Endice, Giulia Furesi, Dorit Breining, Martina Rauner, Lorenz C. Hofbauer, Tilman D. Rachner
Published 2019-06-01

Dickkopf1 fuels inflammatory cytokine responses

by Nikolai P. Jaschke, Sophie Pählig, Anupam Sinha, Timon E. Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwärzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C. Hofbauer, Martina Rauner, Andy Göbel, Tilman D. Rachner
Published 2022-12-01